|
01 Sep 2025 |
Camlin Fine Sciences
|
Consensus Share Price Target
|
203.65 |
295.00 |
- |
44.86 |
hold
|
|
|
|
|
27 May 2016
|
Camlin Fine Sciences
|
Phillip Capital
|
203.65
|
135.00
|
90.05
(126.15%)
|
Pre-Bonus/ Split |
Buy
|
|
|
9 Consolidated sales were lower than our estimates, but a smart >500bps surprise in marginsledto20%higherthanexpectedearnings. 9 FY16PATperformancewas10%aheadofourestimatesduetoa150bpspositivemargin...
|
|
01 Apr 2016
|
Camlin Fine Sciences
|
Phillip Capital
|
203.65
|
135.00
|
90.75
(124.41%)
|
Pre-Bonus/ Split |
Buy
|
|
|
CFIN is an established global leader of foodgrade synthetic antioxidants (market size of ~US$200mn, particularly in Tertbutylhydroquinone (TBHQ) and Butylatedhydroxyanisole (BHA). CFIN has 60% market share (capacity) with TBHQ/BHA capacity of 3600/2400tpa....
|
|
15 Jun 2015
|
Camlin Fine Sciences
|
ICICI Securities Limited
|
203.65
|
110.00
|
90.60
(124.78%)
|
Target met |
Buy
|
|
|
|